Invention Grant
- Patent Title: Therapeutic compounds and uses thereof
-
Application No.: US15658213Application Date: 2017-07-24
-
Publication No.: US10202378B2Publication Date: 2019-02-12
- Inventor: Marc Adler , Daniel J. Burdick , Terry Crawford , Martin Duplessis , Steven R. Magnuson , Christopher G. Nasveschuk , F. Anthony Romero , Yong Tang , Vickie Hsiao-Wei Tsui , Shumei Wang
- Applicant: GENENTECH, INC. , CONSTELLATION PHARMACEUTICALS, INC.
- Applicant Address: US CA South San Francisco US MA Cambridge
- Assignee: GENENTECH, INC.,CONSTELLATION PHARMACEUTICALS, INC.
- Current Assignee: GENENTECH, INC.,CONSTELLATION PHARMACEUTICALS, INC.
- Current Assignee Address: US CA South San Francisco US MA Cambridge
- Agency: Viksnins Harris Padys Malen LLP
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07D471/04 ; A61K31/437 ; A61K31/444 ; A61K31/4545 ; A61K31/5377 ; A61K45/06 ; C07D519/00
Abstract:
The present invention relates to compounds of formula (I): and to salts thereof, wherein R1-R6 have any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of TAF1. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various TAF1-mediated disorders.
Public/Granted literature
- US20180009805A1 THERAPEUTIC COMPOUNDS AND USES THEREOF Public/Granted day:2018-01-11
Information query
IPC分类:
